Very high-risk locally advanced prostate ductal adenocarcinoma cured using low-dose-rate brachytherapy, with seminal vesicle implantation in combination with external beam radiotherapy at a biologically effective dose ≥ 220 Gy: two case reports with a long-term follow-up

PURPOSE: Prostate ductal adenocarcinoma (PDA) is an aggressive, rare variant of histologic sub-type of prostate cancer. Patients with PDA present with more aggressive clinical features and have a poorer prognosis than patients with acinar adenocarcinoma. So far, an optimal treatment for PDA has yet...

Descripción completa

Detalles Bibliográficos
Autor principal: Okamoto, Keisei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720686/
https://www.ncbi.nlm.nih.gov/pubmed/36478704
http://dx.doi.org/10.5114/jcb.2022.119637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720686/
https://www.ncbi.nlm.nih.gov/pubmed/36478704
http://dx.doi.org/10.5114/jcb.2022.119637

Ejemplares similares